PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.34%
Revenue growth 1.25-1.5x TSM's 11.26%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
10.62%
Gross profit growth similar to TSM's 10.94%. Walter Schloss would assume both firms track common industry trends.
10.25%
EBIT growth 50-75% of TSM's 15.14%. Martin Whitman would suspect suboptimal resource allocation.
10.25%
Operating income growth at 50-75% of TSM's 13.84%. Martin Whitman would doubt the firm’s ability to compete efficiently.
11.54%
Net income growth 1.25-1.5x TSM's 10.15%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
13.33%
EPS growth 1.25-1.5x TSM's 10.19%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
11.67%
Diluted EPS growth 1.25-1.5x TSM's 10.19%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-0.17%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.17%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
151.45%
Dividend growth above 1.5x TSM's 13.90%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-5.58%
Negative OCF growth while TSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-9.78%
Negative FCF growth while TSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
2374.66%
10Y revenue/share CAGR above 1.5x TSM's 354.56%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1054.46%
5Y revenue/share CAGR above 1.5x TSM's 200.63%. David Dodd would look for consistent product or market expansions fueling outperformance.
368.27%
3Y revenue/share CAGR above 1.5x TSM's 74.82%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
13570.50%
OCF/share CAGR of 13570.50% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1434.13%
OCF/share CAGR of 1434.13% while TSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
447.93%
3Y OCF/share CAGR of 447.93% while TSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
11683.51%
Net income/share CAGR above 1.5x TSM's 401.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2880.39%
5Y net income/share CAGR above 1.5x TSM's 229.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
609.21%
3Y net income/share CAGR above 1.5x TSM's 68.03%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
1127.36%
10Y equity/share CAGR above 1.5x TSM's 332.87%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
457.67%
5Y equity/share CAGR above 1.5x TSM's 168.36%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
178.95%
3Y equity/share CAGR above 1.5x TSM's 84.93%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
371.18%
10Y dividend/share CAGR above 1.5x TSM's 1.68%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
148.79%
5Y dividend/share CAGR above 1.5x TSM's 82.21%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
149.52%
3Y dividend/share CAGR above 1.5x TSM's 65.64%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
14.29%
Our AR growth while TSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.83%
Inventory growth well above TSM's 3.68%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
10.58%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
18.55%
BV/share growth above 1.5x TSM's 0.34%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-8.88%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
13.60%
R&D growth drastically higher vs. TSM's 8.37%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.37%
We expand SG&A while TSM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.